Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

BACKGROUND: Contemporary to the rapidly evolving landscape of cancer immunotherapy is the equally changing understanding of immune tumor microenvironments (TMEs) which is crucial to the success of these therapies. Their reliance on a robust host immune response necessitates clinical grade measuremen...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomark Res
Главные авторы: Pabla, Sarabjot, Seager, R. J., Van Roey, Erik, Gao, Shuang, Hoefer, Carrie, Nesline, Mary K., DePietro, Paul, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Wang, Yirong, Lenzo, Felicia L., Schoenborn, Margot, Zhang, Shengle, Klein, Roger, Glenn, Sean T., Conroy, Jeffrey M.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2021
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265007/
https://ncbi.nlm.nih.gov/pubmed/34233760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00308-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы